Loading...
LakeShore Biopharma Co., Ltd.
LSBPW•NASDAQ
Healthcare
Biotechnology
$0.03
$-0.00(-5.19%)
LakeShore Biopharma Co., Ltd. (LSBPW) Financial Performance & Statements
Review LakeShore Biopharma Co., Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-16.56%
↓ 16.56%
Operating Income Growth
-219.86%
↓ 219.86%
Net Income Growth
-197.96%
↓ 197.96%
Operating Cash Flow Growth
-61.80%
↓ 61.80%
Operating Margin
-87.20%
↓ 87.20%
Gross Margin
55.29%
↑ 55.29%
Net Profit Margin
-85.97%
↓ 85.97%
ROE
-49.36%
↓ 49.36%
ROIC
-37.32%
↓ 37.32%
LakeShore Biopharma Co., Ltd. (LSBPW) Financial Statements
Explore quarterly and annual reports for LakeShore Biopharma Co., Ltd. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $135.53M | $168.71M | $96.82M | $176.27M |
| Cost of Revenue | $101.12M | $34.90M | $17.51M | $34.68M |
| Gross Profit | $34.41M | $133.81M | $79.31M | $141.59M |
| Gross Profit Ratio | $0.25 | $0.79 | $0.82 | $0.80 |
| R&D Expenses | $58.81M | $68.24M | $78.21M | $100.64M |
| SG&A Expenses | $62.68M | $149.72M | $114.30M | $111.008M |
| Operating Expenses | $215.55M | $217.96M | $179.36M | $210.17M |
| Total Costs & Expenses | $316.67M | $252.86M | $196.87M | $244.85M |
| Interest Income | $0.00 | $30766.00 | $1.96M | $0.00 |
| Interest Expense | $23.64M | $8.35M | $6.90M | $8.03M |
| Depreciation & Amortization | $10.56M | $9.15M | $14.73M | $1.26M |
| EBITDA | -$82.73M | -$72.35M | -$98.48M | -$62.10M |
| EBITDA Ratio | -$0.61 | -$0.50 | -$1.02 | -$0.39 |
| Operating Income | -$181.15M | -$84.16M | -$113.20M | -$70.05M |
| Operating Income Ratio | -$1.34 | -$0.50 | -$1.17 | -$0.40 |
| Other Income/Expenses (Net) | -$13.75M | -$3.44M | $7.99M | -$74000.00 |
| Income Before Tax | -$194.90M | -$87.60M | -$105.22M | -$70.13M |
| Income Before Tax Ratio | -$1.44 | -$0.52 | -$1.09 | -$0.40 |
| Income Tax Expense | -$13.72M | -$7.45M | -$234353.00 | -$586000.00 |
| Net Income | -$181.41M | -$80.15M | -$104.98M | -$69.54M |
| Net Income Ratio | -$1.34 | -$0.48 | -$1.08 | -$0.39 |
| EPS | -$1.72 | -$0.85 | -$1.13 | -$0.75 |
| Diluted EPS | -$1.72 | -$0.85 | -$1.13 | -$0.75 |
| Weighted Avg Shares Outstanding | $14.85M | $93.06M | $93.06M | $93.06M |
| Weighted Avg Shares Outstanding (Diluted) | $14.85M | $93.06M | $93.06M | $93.06M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan